Yahoo Finance Globus Medical Full Year 2022 Earnings: EPS Misses Expectations
Globus Medical (NYSE:GMED) Full Year 2022 Results
Key Financial Results
Revenue: US$1.02b (up 6.8% from FY 2021).
Net income: US$190.2m (up 28% from FY 2021).
Profit margin: 19% (up from 16% in FY 2021). The increase in margin was driven by higher revenue.
EPS: US$1.89 (up from US$1.48 in FY 2021).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Globus Medical EPS Misses Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 2.1%.
Looking ahead, revenue is forecast to grow 7.9% p.a. on average during the next 3 years, compared to a 7.5% growth forecast for the Medical Equipment industry in the US.
Performance of the American Medical Equipment industry.
The company's shares are down 1.8% from a week ago.
Balance Sheet Analysis
Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. See our latest analysis on Globus Medical's balance sheet health.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here
